` Comparison: NOVO B, MRK - Alpha Spread

NOVO B
vs
MRK

Over the past 12 months, NOVO B has underperformed MRK, delivering a return of -59% compared to the MRK's 10% drop.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
NOVO B
MRK
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

NOVO B Intrinsic Value
499.38 DKK
Undervaluation 39%
Intrinsic Value
Price
MRK Intrinsic Value
125.53 USD
Undervaluation 30%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Novo Nordisk A/S
CSE:NOVO B
306.35 DKK
Merck & Co Inc
NYSE:MRK
88.1 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
NOVO B, MRK

NOVO B
MRK
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Novo Nordisk A/S
Revenue
Merck & Co Inc
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
NOVO B, MRK

NOVO B
MRK
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Novo Nordisk A/S
CSE:NOVO B
Merck & Co Inc
NYSE:MRK
What is Free Cash Flow?

Gross Margin

NOVO B
82.1%
MRK
78.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Novo Nordisk A/S
Merck & Co Inc

Operating Margin

NOVO B
42%
MRK
38.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Novo Nordisk A/S
Merck & Co Inc

Net Margin

NOVO B
32.9%
MRK
29.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Novo Nordisk A/S
Merck & Co Inc

FCF Margin

NOVO B
19.3%
MRK
20.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Novo Nordisk A/S
Merck & Co Inc

ROE

NOVO B
71.5%
MRK
39.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Novo Nordisk A/S
Merck & Co Inc

ROA

NOVO B
22.8%
MRK
15.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Novo Nordisk A/S
Merck & Co Inc

ROIC

NOVO B
27.7%
MRK
20.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Novo Nordisk A/S
Merck & Co Inc

ROCE

NOVO B
56.8%
MRK
25.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Novo Nordisk A/S
Merck & Co Inc

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
NOVO B, MRK

Loading

Performance Gap
NOVO B, MRK

Loading
NOVO B
MRK
Difference
www.alphaspread.com

Performance By Year
NOVO B, MRK

Loading
NOVO B
MRK
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare NOVO B to other stocks
Unlock Full Access to Alpha Spread
Create Free Account